Pharmacy Is Right For Me

NOVEMBER 4, 2024

Meet Lila, a passionate fourth-year Pharm.D. student at Auburn University Harrison College of Pharmacy. During her APPE rotation with the American Association of Colleges of Pharmacy , Lila opened up about her inspiring journey to find the perfect pharmacy school and how, with the guidance of mentors, she discovered her true “Pharmily.” How did you choose your pharmacy school/college or graduate program?

230

230

Drug Topics

NOVEMBER 4, 2024

Ruth Carrico PhD, DNP, APRN, discussed the importance of annual vaccination and overall health awareness and literacy during the winter flu season.

Vaccines 210

Vaccines 210

STAT

NOVEMBER 4, 2024

This is Part 5 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market. Lower prices are good news for patients seeking more affordable medications, but the change can sometimes take a while.

Medicine Expiration 133

Medicine Expiration Insurance 133

Drug Topics

NOVEMBER 4, 2024

The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.

FDA 201

FDA 201

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

NOVEMBER 4, 2024

Compared with a short-acting β agonist (SABA) alone, inhaled corticosteroids (ICS) with formoteral and ICS with a SABA were associated with better asthma control.

131

131

Fierce Pharma

NOVEMBER 4, 2024

As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against competitors.

123

123

Drug Topics

NOVEMBER 4, 2024

Ruth Carrico, PhD, DNP, APRN, discussed declining influenza and COVID-19 vaccination rates and how it has created a looming threat for public health officials.

Vaccines 123

Vaccines 123

Pharmacy Times

NOVEMBER 4, 2024

The randomized, placebo-controlled RESCUE phase 3 trial assessed clofutriben among individuals with ACTH-dependent endogenous Cushing syndrome.

FDA 123

FDA 123

Fierce Healthcare

NOVEMBER 4, 2024

Senators Bill Cassidy, M.D., R-Louisiana, and Maggie Hassan, D-New Hampshire, published a policy paper advocating to impose site-neutral Medicare payments on hospitals. | The lawmakers argue that site-neutral Medicare payment reform would lead to lower healthcare costs for patients and save taxpayer dollars. However, hospital groups were quick to slam the proposal.

Hospitals 122

Hospitals 122

Fierce Pharma

NOVEMBER 4, 2024

BioNTech reported surprisingly strong sales of its COVID-1 | BioNTech reported surprisingly strong sales of its COVID-19 vaccine in the third quarter. Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2.5 billion to €3.1 billion.

Vaccines 122

Vaccines 122

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Checkup by Singlecare

NOVEMBER 4, 2024

Diabetes is a medical condition that occurs when your body can’t regulate blood sugar levels. Consistently elevated blood sugar causes health problems, such as heart disease, kidney disease, and nerve damage, particularly in your feet and eyes. Diabetes treatment usually includes medications , such as oral medications, non-insulin injectable medicines, and sometimes insulin , depending on which type of diabetes you have as well as your blood glucose control.

Compounding 93

Compounding People Management Dosage Labelling 93

pharmaphorum

NOVEMBER 4, 2024

Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD

119

119

Pharmacy Times

NOVEMBER 4, 2024

It is more important than ever to have pharmacists and pharmacy professionals practicing at the top of their license to assist patients in pharmacy deserts.

108

108

pharmaphorum

NOVEMBER 4, 2024

Novo Nordisk puts $285m into a once-monthly GLP-1 agonist for obesity using technology developed by fellow Danish pharma Ascendis

112

112

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

NOVEMBER 4, 2024

The word “Tuskegee” has long embodied the painful symbol of medical racism, epitomizing how ethnically uninformed research practices have harmed Black Americans. It is impossible to erase this painful history. But we — one of us working for Tuskegee University, the other for Southern Research — are working on an innovative project to create a future in which Black Americans participate more fully in clinical research and share in its benefits.

120

120

pharmaphorum

NOVEMBER 4, 2024

Accord Healthcare unveils £50m investment, backed by the UK government, that will see a new manufacturing facility built in Newcastle

111

111

Fierce Pharma

NOVEMBER 4, 2024

Dermatology drugmaker Journey Medical has trekked its Dr. Reddy’s Laboratories-partnered rosacea med across the FDA finish line as Emrosi. | The drug proved superiority in clearing lesions over Galderma's standard-of-care Oracea capsules in phase 3 studies, leaving Journey to deploy its dermatology sales force to establish Emrosi as a dominant treatment.

FDA 98

FDA 98

pharmaphorum

NOVEMBER 4, 2024

Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

111

111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

NOVEMBER 4, 2024

UnitedHealthcare is growing its reach on the Affordable Care Act's (ACA's) exchanges and will offer plans in 30 states for 2025. | UnitedHealthcare is growing its reach on the Affordable Care Act's exchanges and will offer plans in 30 states for 2025.

98

98

pharmaphorum

NOVEMBER 4, 2024

NHS England starts pilot trial of an iPhone app and device that could be used by nurses to speed up reviews of suspected throat cancer cases.

110

110

Pharmaceutical Technology

NOVEMBER 4, 2024

Researchers from Northwestern and Case Western Reserve universities have developed a polymer therapeutic to treat Huntington's disease.

97

97

pharmaphorum

NOVEMBER 4, 2024

US district court grants an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata

110

110

Pharmaceutical Technology

NOVEMBER 4, 2024

The US FDA has granted fast track designation to FELIQS’ lead product FLQ-101 for preventing retinopathy of prematurity (ROP).

FDA 97

FDA 97

STAT

NOVEMBER 4, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Need a distraction from your election anxiety? May I suggest the new album from Québécois fiddle whizzes Alexis Chartrand and Nicolas Babineau, which dropped on Friday and has us trad heads abuzz?

92

92

Fierce Pharma

NOVEMBER 4, 2024

Despite winning an alopecia areata approval for its drug Leqselvi in July, Sun Pharma will have to wait a while longer to launch its JAK inhibitor competitor to Eli Lilly and Incyte’s Olumiant and | Sun Pharma, which had been plotting a mid-October launch for its JAK inhibitor Leqselvi, has been slapped with in an injunction blocking the rollout of the alopecia areata drug.

119

119

Outsourcing Pharma

NOVEMBER 4, 2024

Thermo Fisher Scientific has joined forces with Labguru to integrate Labguruâs Electronic Lab Notebook (ELN) into Thermo Fisherâs Laboratory Information Management System (LIMS) and lab operations software.

82

82

Pharmacy Times

NOVEMBER 4, 2024

Julie Sibbesen, PharmD,

81

81

Fierce Healthcare

NOVEMBER 4, 2024

Days before the 2024 presidential election, the Centers for Medicare & Medicaid Services (CMS) released an unpublished version of the final calendar year 2025 physician fee schedule final rule | Digital therapeutics, telehealth, rural heath clinics and opioid treatment programs all got updates in the final 2025 Medicare physician fee schedule rule, but CMS was limited by its statutory authority to make many substantial changes to digital health policy.

128

128

STAT

NOVEMBER 4, 2024

Recently, the smoldering embers of conflict in my family’s rare disease community have burst into flames over the use of an eponym: Niemann-Pick. An eponym is a name derived from a person who first discovered a disease or who was otherwise closely associated with its identity. Such was the case for a neurodegenerative condition observed in a child and documented by Alfred Niemann in 1914.

Documentation 95

Documentation 95

Fierce Pharma

NOVEMBER 4, 2024

While Eli Lilly and Novo Nordisk had market cap declines in the third quarter, Bristol Myers Squibb, Gilead Sciences and Sanofi saw their value increase, according to GlobalData.

69

69

Pharmacy Times

NOVEMBER 4, 2024

Recently announced trial results demonstrate the efficacy of the biologic in multiple disease indications.

65

65

STAT

NOVEMBER 4, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Morning! Today, we see even further potential for GLP-1 drugs, this time in MASH. We look at China’s probe into AstraZeneca, and have a cool video on patent thickets.

89

89

Pharmacy Times

NOVEMBER 4, 2024

The study investigated faricimab-svoa (Vabysmo) as treatment of diabetic macular edema for patients in racial and ethnic groups that are often underrepresented in trials.

65

65